Amiprostone 24 Mcg 30 Cap

Amiprostone 24 Mcg 30 Cap

Description:

Amiprostone 24 mcg 30 cap is a prescription oral medication containing lubiprostone, used to treat chronic constipation conditions in adults. It acts locally in the intestine to increase intestinal fluid secretion and enhance bowel motility, helping to relieve hard stools, infrequent bowel movements, and straining. This medicine is commonly prescribed for chronic idiopathic constipation, irritable bowel syndrome with constipation (IBS‑C) in adult females, and opioid‑induced constipation associated with chronic non‑cancer pain.

Indications:

• Treatment of chronic idiopathic constipation (CIC) in adults.
• Treatment of irritable bowel syndrome with constipation (IBS‑C) in adult females aged 18 years and older.
• Treatment of opioid‑induced constipation (OIC) in adults with chronic non‑cancer pain.
• Relief of constipation symptoms such as infrequent bowel movements, hard or lumpy stools, excessive straining, and feeling of incomplete evacuation.

Active Ingredients / Key Components:

• Lubiprostone – 24 mcg per capsule.
• Other inactive ingredients (excipients) are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not exceed the recommended dose.
• Adults – Chronic Idiopathic Constipation (CIC): 24 mcg orally twice daily.
• Adult Females ≥18 years – Irritable Bowel Syndrome with Constipation (IBS‑C): 8 mcg orally twice daily.
• Adults – Opioid‑Induced Constipation (OIC) with Chronic Non‑Cancer Pain: 24 mcg orally twice daily.
• Swallow the capsule whole with water; do not crush or chew.
• It is usually recommended to take with food and water to help reduce nausea; follow your doctor’s instructions.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Duration of treatment depends on your medical condition and response; use only under medical supervision.

Clinical Benefits:

• Helps relieve chronic idiopathic constipation by increasing intestinal fluid secretion and promoting regular bowel movements.
• Improves symptoms of irritable bowel syndrome with constipation (IBS‑C) in adult females, including abdominal discomfort and difficulty passing stools.
• Reduces constipation associated with long‑term opioid use in chronic non‑cancer pain patients.
• Decreases straining and improves stool consistency, making bowel movements easier and more comfortable.
• Acts locally in the gastrointestinal tract with minimal systemic absorption, which may reduce systemic side effects compared to some other laxative therapies.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to lubiprostone or any component of the product.
• Contraindicated in patients with known or suspected mechanical gastrointestinal obstruction; do not use unless obstruction has been ruled out by a physician.
• Use with caution in patients with severe diarrhea; discontinue and contact your doctor if severe diarrhea occurs.
• May cause nausea, especially at the start of therapy; taking with food and water may help.
• Consult your doctor before use if you are pregnant or planning pregnancy. Use in pregnancy only if clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding; it is not known with certainty if lubiprostone passes into breast milk.
• Use with caution in patients with severe liver impairment; dose adjustment may be required as per physician’s judgment.
• Inform your doctor about all other medications you are taking, including laxatives, opioids, and other gastrointestinal drugs.
• Consult your doctor before use if you have a history of severe diarrhea, inflammatory bowel disease, or other serious gastrointestinal conditions.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, diarrhea, abdominal pain or discomfort, abdominal distension, gas (flatulence), headache.
• Less common side effects: vomiting, dry mouth, dizziness, fatigue.
• Serious side effects (seek medical attention immediately): severe or persistent diarrhea, severe abdominal pain, signs of allergic reaction such as rash, itching, swelling of the face or tongue, severe dizziness, or difficulty breathing.
• If any side effect is severe, persistent, or you notice any unusual symptoms, stop taking the medicine and contact your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at room temperature unless otherwise specified on the pack. Do not use if the blister or packaging is damaged.

Specifications:

• Product type: Prescription medicine for constipation management.
• Active ingredient strength: lubiprostone 24 mcg per capsule.
• Form: oral capsule.
• Pack size: 30 capsules per pack.
• Intended use: adults (and adult females for IBS‑C) under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.